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Abstract 
Older adults often experience memory impairments, but can sometimes use selective processing 
and schematic support to remember important information.  The current experiments investigate 
to what degree younger and healthy older adults remember medication side effects that were 
subjectively or objectively important to remember.  Participants studied a list of common side 
effects, and rated how negative these effects were if they were to experience them, and were then 
given a free recall test.  In Experiment 1, the severity of the side effects ranged from mild (e.g., 
itching) to severe (e.g., stroke), and in Experiment 2, certain side effects were indicated as 
critical to remember (i.e., “contact your doctor if you experience this”).  There were no age 
differences in terms of free recall of the side effects, and older adults remembered more severe 
side effects relative to mild effects. However, older adults were less likely to recognize critical 
side effects on a later recognition test, relative to younger adults. The findings suggest that older 
adults can selectively remember medication side effects, but have difficulty identifying familiar 
but potentially critical side effects, and this has implications for monitoring medication use in 
older age.   
   
Keywords: memory, aging, medications, side effects, older adults 
Word count: 6,471 
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 When faced with large quantities of information, one often needs to be selective and 
prioritize the information to maximize the likelihood that important information is processed and 
later recalled.   Older adults often take several different medications and may need to monitor all 
of the potential side effects of their medications. Side effect information can be quite extensive, 
and consists of long lists of potential side effects.  Given the prevalence of medication usage in 
older adult populations (Qato et al., 2008), as well as college students’ increasing use of various 
medications for a variety of both mental and physical conditions and symptoms (White, Becker-
Blease, & Grace-Bishop, 2006), it is critical to determine factors that can reduce the risks 
associated with the consumption of multiple medications.  Thus, it is often necessary for people 
to accurately monitor and be aware of all of the potential side effects that are associated with a 
particular medication, and to know which side effects could be indicative of a serious 
complication.  Given the fact that a majority of medications are associated with a lengthy list of 
potential side effects, one’s ability to remember these side effects can be paramount in 
monitoring one’s health.   
This ability to recall important health-related information is particularly critical for older 
adults, who often experience memory deficits.  The most pronounced age-related deficits are 
when remembering specific events or details (Zacks & Hasher, 2006), and associations among 
pairs of events or items (Chalfonte & Johnson, 1996; Naveh-Benjamin, 2000), and these deficits 
are often observed when older adults are presented with large amounts of to-be-remembered 
information, such as long lists of words (see Cohen, Sandler, & Schroeder, 1987).  However, 
under some circumstances and conditions, older adults display preserved forms of memory 
(Zacks & Hasher, 2006; McDaniel, Einstein, & Jacoby, 2008), suggesting that not all memory 
abilities decline uniformly with age.  For example, older adults can remember information that is 
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related to previously learned semantic knowledge (e.g., Hess & Slaughter, 1990) and information 
that is consistent with relevant real-world conditions (Hess, 2005). That is, older adults can 
utilize schematic support, which is the use of prior knowledge or semantic memory to aid in the 
processing of new information and the facilitation of encoding and retrieval (Craik, 2002; Craik 
& Bosman, 1992; for a recent review see Umanath & Marsh, 2014). For example, Castel (2005) 
found that older adults, compared to younger adults, were equally able to remember realistic 
prices of grocery items (e.g., pickles $3.29) but were impaired for unrealistic pairings (e.g., ice 
cream $17.59), suggesting that prior knowledge, expectations, and goals may have a substantial 
impact on older adults’ memory.  Additionally, Miller (2003) showed that older adults and 
younger adults with high levels of knowledge in the context of cooking recalled similar amounts 
of cooking-related text information, but older adults remembered less information than younger 
adults for domain-unrelated text passages about biology.  Older adults also benefit from prior 
task success (Geraci & Miller, 2013), such that if older adults can succeed on certain memory 
tasks with relevant materials, age-related memory differences may be reduced.  However, other 
work has shown limited or negligible effects of task experience, expertise, or schematic support, 
such as when older pilots were asked to remember air traffic control messages (Morrow, Menard, 
Stine-Morrow, Teller, & Bryant, 2001), or when prior knowledge could improve memory for 
prose passages or spatial layouts (Arbuckle, Cooney, Milne, & Melchior, 1994). Thus, it is 
unclear how and when certain forms of experience or knowledge, such as knowledge of common 
medication side effects, can influence older adults’ memory and potentially reduce age-related 
differences.  
Theoretical frameworks regarding older adults’ ability to recall information deemed more 
important, realistic, or relevant suggests that older adults engage in “selective optimization with 
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compensation”, allowing for the selective focus on important or goal-related information and 
activities, at the expense of less important or relevant information and activities (Baltes & Baltes, 
1990; see also Backman & Dixon, 1992).  This selectivity is particularly apparent within tasks 
that explicitly vary the objective value of the to-be-remembered information. According to a 
“value-directed remembering” framework (Castel, 2008; Castel, McGillivray, & Friedman, 
2012), older adults can remember higher-value information as well as younger adults by 
selectively prioritizing and encoding this information over less important information (Castel, 
Benjamin, Craik, & Watkins, 2002; Castel et al., 2013). Furthermore, McGillivray and Castel 
(2011) demonstrated that both younger and older adults can learn to selectively choose to focus 
on and remember high value items when there are consequences associated with the failure to 
recall this higher value information. Thus, despite memory deficits, under some conditions older 
adults can efficiently learn to employ strategies that enhance recall of selected information. In 
the context of memory for medication side effects, the value-directed remembering framework 
could explain why older adults may remember some side effects better than others, in that certain 
specific side effects might be perceived as more subjectively valuable or important to the 
individual. 
 In prior research studies, important information was usually defined by association with 
objective point values that indicated higher reward values, and the point values were assigned by 
the experimenter.  However, in many situations, the individual must decide what is important to 
remember.  For example, when packing for a trip one needs to remember to pack certain 
important items, and older adults can selectively remember important items that are task relevant 
(McGillivray & Castel, under review). While prior research has examined how older adults can 
remember important information when the value is pre-assigned to items by the experimenter 
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(see Castel, McGillivray, & Friedman, 2012, for a review), it is essential to examine situations in 
which participants themselves must decide what is more or less important to remember. This 
goal of “subjective” selectivity allows for the strategic allocation of attention towards what is 
deemed important by either the individual or the task setting (see also Hess, 2005; Stine-Morrow, 
2007). Thus, importance can be defined objectively (generally important as stated by others or 
via reward) or subjectively (information that is important to the individual, specifically).  
The current study examines whether the perceived importance of certain medication side 
effects influences younger and older adults’ ability to later remember these side effects. Often 
times, potential side effects are presented in rapid succession or in long lists, making it difficult 
to focus on and remember all of the side effects.  However, in many cases, it is perhaps more 
critical to remember certain important or severe side effects, as opposed to attempting to 
remember all of the side effects. Thus, goals to selectively remember subjectively and 
objectively important and essential information could be particularly helpful to older adults when 
they are presented with a long list of potential side effects.  In the present experiments, we 
examined whether younger and older adults could selectively remember side effects of a 
hypothetical medication.  Participants studied a list of side effects and were told to remember the 
side effects for a later memory test.  In Experiment 1, the severity of the presented side effects 
was manipulated (mild: brittle nails, cough; moderate: diarrhea, rash; severe: paralysis, heart 
attack), with participants providing a subjective rating of severity for each side effect while it 
was presented.  In Experiment 2, despite all of the presented side effects being relatively mild or 
moderate in severity, their severity was objectively manipulated such that certain side effects 
were marked as ones that should be reported to a doctor immediately if experienced (contact 
your doctor, or “CYD”).  
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We were interested in whether age-related differences in the recall of side effects would 
be present, or if they may be small or negligible as a result of older adults’ use of schematic 
support.  Due to older adults’ experience with taking medication and learning about the 
associated side effects in their everyday lives (Qato et al., 2008), older adults may be able to rely 
on schematic support in this context (Castel, 2005; Craik, 2002; Craik & Bosman, 1992; Hess, 
2005; Miller, 2003; Umanath & Marsh, 2014). However, it is unclear whether participants in this 
task will remember some side effects better than others, based on the subjectively assigned 
negativity ratings, or the objective severity. Given that older adults typically encounter more 
physical health issues than younger adults (cf., Wolinsky & Johnson, 1991), they may construe 
the severe side effects as concerning. Thus, older adults may feel it is necessary to attend to (and 
remember) the severe side effects when visiting/reporting to a doctor. Based on the prior 
research on value-directed remembering (Castel, 2008; Castel et al., 2002), and the salience of 
experiencing certain side effects, we expect small or negligible age-related differences in recall 
for the severe side effects, and larger age-difference in recall for the moderate and mild side 
effects..  This may be a result of older adults selectively focusing on valuable information, in this 
case the severe side effects, in light of being aware that due to memory impairments, not all of 
the side effects will be recalled. As younger adults do not face concerns regarding memory 
impairments, younger adults may be less selective than older adults and try to remember all of 
the to-be-remembered information, and not prioritize more severe side effects over less severe 
ones.  
Experiment 1 
 To examine potential age-related differences in memory for side effects, younger and older 
adult participants studied and recalled a list of common medication side effects that could be 
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classified into three “severity” categories: mild, moderate, and severe.  By manipulating the 
severity of side effects in this way, participants would likely give quantitatively different ratings 
to each side effect category-type, providing some evidence regarding how those objective 
categories and subjective ratings may impact memory performance.  Although younger adults 
typically outperform older adults on most tests of free recall, age-related differences in memory 
might be reduced in the present task, due to the relative prior experience or schematic support 
older adults have with medication side effects.  Thus, Experiment 1 allowed for the investigation 
of potential age-related differences or similarities in the ability to remember side effects, and to 
what degree recall would be influenced by the subjective ratings.   
Method 
 Participants.  Twenty-four undergraduate students (5 males, average age = 20.3) from the 
University of California, Los Angeles and 24 older adults (11 males, average age = 73.5) from 
the surrounding community were recruited for this task.  Older adults were living independently 
in the Los Angeles area, and were recruited through community flyer postings as well as through 
the UCLA Cognition and Aging Laboratory Participant Pool. Older adults were compensated 
with $10 an hour for participation, while younger adults received course credit for their 
participation. 
 Materials.  The materials consisted of 21 side effects that were selected from an internet 
database (http://www.vaughns-1-pagers.com/medicine/prescription-drug-side-effects.htm) for 
medication side effects. The selected side effects were classified into three separate severity 
categories: mild (e.g., itching), moderate (e.g., heartburn), and severe (e.g., stroke) side effects. 
Each side effect was categorized a priori based on the classification of the side effects in drug 
advertisements approved by the Food and Drug Administration, as well as by independent raters 
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(two undergraduate students who were not participants) and the experimenters, into one of the 
three groups based on its severity, such that there were seven side effects in each severity 
category.   
 Procedure.  Participants were told they were going to be shown a list of side effects for a 
new, hypothetical medication, one at a time.  As each side effect was presented, participants 
were asked to rate how negative or unpleasant they felt experiencing each side effect would be 
for them on a scale from 1 to 10, where 1 = would not be an issue (not very concerning), and 10 
= would be an extremely big issue (and very concerning) if they experienced that specific side 
effect.  The term “issue” or “concern” was used to indicate and emphasize that the participant 
could use the entire scale as certain side effects may be more/less concerning for specific 
individuals or situations.  After studying the side effects, they would be asked to recall as many 
of the side effects as they could, in any order.  Participants saw each side effect in the center of 
the screen in black 44-point Arial font on a white background. Participants verbally provided a 
rating for each side effect during the 5 s for which it was on the screen, before the next side 
effect was shown.  Participants were randomly assigned to view the list of side effects in one of 
four different fixed-randomized orders.  The order of the side effects was blocked randomized 
such that within each block of three items, one side effect from each of the severity categories 
was presented. The order of each block was randomized across four versions of the experiment.  
Although the severity of the side effects was pre-determined, the three categories (i.e., mild, 
moderate, severe) were never explicitly mentioned to the participants. After studying the last side 
effect, participants had 1 min to verbally recall as many of the studied side effects as they could.  
The experimenter recorded their verbal responses.  After completing the free recall task, two 
post-test questions were asked of participants: how did they try to remember the side effects they 
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studied, and whether they pay attention to the side effects of medication they are currently taking 
or have taken in the past. 
Results and Discussion 
 The average ratings assigned to the side effects and the proportions of side effects 
recalled by age group are shown in Figure 1.  A 2 (Age Group: younger adults, older adults) x 3 
(Severity Category: mild, moderate, severe) mixed ANOVA on ratings found a main effect of 
severity category, F(2, 92) = 561.45, MSE = .68, p < .001, ηG
2
 = .77, such that severe side effects 
(M = 8.65, SD = 1.07) were rated as more negative than moderate effects (M = 5.02, SD = 1.39), 
t(47) = 23.57, p < .001, d = 2.92, which in turn were rated as more negative than mild effects (M 
= 3.11, SD = 1.43), t(47) = 12.87, p < .001, d = 1.35. The effect of age group was not significant, 
F(1, 46) = 3.33, MSE = 3.59, p = .07, ηG
2
 = .05. The interaction between age groups and severity 
categories was non-significant, F(2, 92) = 2.09, MSE = .67, p = .13, ηG
2
 = .01. Given that older 
adults typically report more physical health issues than younger adults, and thus may construe 
the side effects as concerning, and necessary to attend to (and remember) when reporting to a 
doctor, we conducted post-hoc t-tests that indicated older adults rated mild side effects as more 
negative (M = 3.59, SD = 1.80) than did younger adults (M = 2.62, SD = 0.69), t(46) = 2.47, p = 
.02, d = .71, but the comparisons between younger and older adults’ ratings for moderate and 
severe side effects were similar (ts < 1.3). 
 The proportion of side effects recalled is shown in the lower portion of Figure 1. A 2 (Age 
Group: younger adults, older adults) x 3 (Severity Category: mild, moderate, severe) mixed 
ANOVA on recall found no significant effect of age group (F < 1), but an effect of severity, F(2, 
92) = 4.91, MSE = .04, p < .01, ηG
2
 = .06, such that moderate side effects (M = .52, SD = .21) 
were recalled less often than mild (M = .61, SD = .20), t(47) = 2.03, p = .048, d = .43,  or severe 
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side effects (M = .64, SD = .19), t(47) = 2.84, p < .01, d = .59. Additionally, age group 
significantly interacted with severity category, F(2, 92) = 3.24, MSE = .04, p = .04, ηG
2
 = .04, 
such that older adults recalled a similar number of mild and moderate side effects, t(23) = 0.01, 
but more severe effects than mild effects,  t(23) = 2.36, p < .05, d = .56, and marginally more of 
the moderate effects, t(23) = 2.01, p = .06, d = .54. Younger adults showed a different pattern of 
results, such that mild effects were recalled more often than moderate effects, t(23) = 3.36, p < 
.01, d = .96, while severe side effects were remembered marginally more often than moderate 
effects, t(23) = 1.97, p = .06, d = .62. Additionally, although a larger proportion of older adult 
participants (58%) reported that they pay attention to the listed side effects of medications they 
are currently taking relative to younger adults (38%), when we compared these two groups in 
terms of ratings and recall, there were no significant differences, although given the limited 
number of participants in each group, this type of analysis was limited by low power. 
 As an ancillary analysis, we further investigated the potential impact of participants’ 
severity ratings (i.e., subjective value) on their memory for specific side effects As subjective 
ratings were made on a trial-by-trial basis on a continuous scale, we conducted a trial-level 
mixed-effects modeling to examine the effects of subjective ratings, age group, and their 
interaction (Baayen, Davidson, & Bates, 2008; Murayama, Sakaki, Yan, & Smith, 2014). In this 
model, participants’ subjective ratings (standardized within individuals), age group, and rating by 
age interaction terms were included as trial-level predictors of memory performance, with 
participants and items being independent random effects. The model also included a quadratic 
effect of subjective ratings and its interaction with age group. We used a standard logit-link 
function to handle the dichotomous dependent variable (i.e., memory performance). The results 
from this analysis showed a significant positive quadratic effect, Exp (B) = 1.32, p < .01, 
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indicating that subjective ratings have an overall nonlinear effect on memory performance. More 
importantly, there was a linear effect by age group interaction, Exp (B) = 1.17, p < .05, 
indicating that older adults had a higher linear slope, Exp (B) = 1.31, than younger adults, Exp 
(B) = 0.96. For reference, the exponential beta value, Exp (B), in generalized mixed-effects 
models can be interpreted in the same way as logistic regression analysis. Specifically, 
exponential beta is interpreted as the effect of the independent variable on the odds ratio of 
successful memory recall (i.e., the probability of recalling items divided by the probability of 
forgetting them). For example, Exp (B) = 1.17 means that the odds that an item is recalled is 
increased by 1.17 times as the standardized severity rating is increased by 1. After accounting for 
the overall quadratic trend, these findings suggest that older adults recalled more subjectively 
severe effects than moderate or mild effects whereas this trend was not observed in younger 
adults. 
 The results of this experiment illuminate an interesting relationship between subjective 
ratings (or value), age group, and memory. Specifically, older adults remembered more severe 
side effects than mild or moderate side effects. This pattern of results was found in both the 
ANOVA, as well as the mixed-effects modeling. However, younger adults showed a different 
pattern than older adults, in that they recalled as many mild side effects as they did severe side 
effects. This curvilinear relationship between value and memory has been found in other research 
(Madan & Spetch, 2012), and could be explained by two alternatives. The first explanation is 
that younger adults have better memory for extreme values, rather than only the high-value 
information (reward salience and reward value, respectively; see Madan & Spetch, 2012).  The 
reward salience explanation is plausible, as participants were never provided with instructions to 
remember specific, important side effects over less important ones. The alternate explanation is 
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one of relative experience. Namely, younger adults likely have had less experience with the 
moderate or severe side effects relative to the mild ones. As a result, younger adults may have 
elected to focus their encoding and rehearsal efforts on the side effects they had experienced in 
the past (i.e., the mild ones). Several participants (both younger and older) reported post-test that 
they tried to remember side effects they had previously experienced, giving this explanation 
some validity. Conversely, older adults may have relatively more experience with side effects 
from all three categories, simply having lived longer and having likely experienced more of these 
effects overall, which could explain why they selectively focused on only the severe side effects.  
 Consistent with the value-directed remembering framework (Castel, 2008), it may be that 
older adults elected to focus on the severe side effects because they could not remember 
everything that was studied, so they chose to focus on the side effects they felt were most 
important or were more harmful. Older adults may have also found the severe side effects to be 
more emotionally arousing than the mild or moderate side effects, thus leading to enhanced 
recall for these items, as such arousing information may garner additional attention and 
processing for older adults (Mather & Carstensen, 2003). Although this is typically found for 
emotionally-positive information for older adults, medication side effects may be viewed as 
more salient and emotional for older adults, due to any potential changes in health and/or more 
experience visiting doctors, possibly leading to enhanced elaborative processing or greater self-
reference to one’s own experience with these symptoms.  
Experiment 2 
 Experiment 2 was designed to investigate the extent to which younger and older adults 
could both recall and recognize objectively important side effect information.  In Experiment 2, 
all of the side effects were relatively mild or moderate.  However, within the instructions, 
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participants were encouraged to selectivity attend to and remember specific side effects.  Many 
contemporary medication advertisements come with warnings that certain mild side effects may 
be indicative of a severe complication.  This warning, in effect, makes typically low-value 
information suddenly important to remember. Thus, some relatively mild side effects (e.g., sore 
throat) may be critical to remember, as they are indicative of a potentially life-threatening 
condition. Within Experiment 2, a subset of the side effects presented were labeled as important 
and should be immediately reported to a doctor if experienced (“contact-your-doctor” side 
effects, or “CYDs”). Memory for the side effects was assessed using a free recall test and was 
then followed by a recognition source memory task, in which participants had to identify which 
of the side effects were indicative of the severe complications (i.e., the CYD, contact-your-
doctor effects).  We refer to this as a source recognition task, as participants were NOT asked to 
identify all of the previously presented side effects (as might be the case in a typical recognition 
task), but rather to identify only the five CYD side effects among the group of 20 previously 
presented side effects.   
While schematic support may facilitate recall, it is possible that older adults will have 
greater difficulty with the source recognition task compared with younger adults. Specifically, a 
lifetime of experience with the mild to-be-remembered side effects likely will lead to a greater 
degree of proactive interference when identifying the CYD effects. After all, why should a side 
effect like a cough, which an older adult has viewed their entire life as common and usually not 
important, suddenly become more important to remember than back pain? Such a finding may 
illustrate one potential cost of schematic support, in that older adults may be able to recall as 
much information as younger adults, yet may also have an inability to update the value of 
information in memory due to extensive proactive interference (cf. Friedman & Castel, 2013). In 
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addition, work by Jacoby and colleagues has shown that older adults have relatively higher false 
alarm rates than younger adults due to a reliance on familiarity and not recollection (e.g., Jacoby, 
1991; Jacoby, Bishara, Hessels, & Toth, 2005; Jacoby, Walheim, Rhodes, Daniels, & Rogers, 
2010; Jones & Jacoby, 2005; Rhodes, Castel, & Jacoby, 2008).  Thus, the use of familiarity on 
the source recognition test could lead to higher rates of false alarms for older adults. 
Method 
 Participants.  Twenty-four undergraduates (10 males, average age = 21.5) from the 
University of California, Los Angeles and 24 older adults (11 males, average age = 71.2) from 
the surrounding community were recruited for this task, and none of the participants had 
participated in Experiment 1.  Older and younger adults were recruited and compensated in the 
same manner described in Experiment 1. 
 Materials.  The materials were similar to those in Experiment 1 with the following 
exceptions: Twenty mild and moderate medication side effects (e.g., nausea, sweating, headache, 
etc.) were presented, such that all of the side effects selected for this experiment were temporary 
in their duration (although the selected side effects could occur chronically as well), such that 
they could be counterbalanced to be either CYD or non-CYD side effects. 
 Procedure.  The procedure was similar to Experiment 1, in that side effects were studied 
and rated, followed by a free recall test.  However, participants were instructed that a subset of 
the side effects that they studied, if experienced, were indicative of a serious complication, and 
that they would need to contact their doctor immediately if they experienced any of those 
specific symptoms (contact-your-doctor side effects, CYDs).  That is, some of the to-be-
remembered side effects were objectively made more valuable and important for the participant 
to remember relative to others, despite the fact that they could be mild or moderate in nature.  
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Those objectively severe, or CYD, side effects were a subset of five of the 20 side effects, 
randomly selected across the entire list and counterbalanced across participants. The CYD side 
effects were shown in red font rather than black font to indicate that they were important for the 
participants to identify and later report.  The order of the side effects studied was blocked 
randomized such that within each block of 4 side effects, one side effect was identified as a CYD 
effect.  
 Following the 1 min free recall test, participants engaged in a recognition source memory 
test to identify the five CYD side effects out of the 20 side effects initially studied. The 
experimenter read aloud the name of each side effect to the participant in the order in which they 
were presented during the learning portion of the experiment. As each side effect was read aloud, 
the participant had to respond by saying “yes” or “no” as to whether that specific side effect was 
one of the CYD side effects. After the participant made their judgment on the last side effect, he 
or she proceeded to answer the post-test questions used in Experiment 1 before being debriefed.        
Results and Discussion 
 The mean proportion of recalled side effects and the average ratings assigned to the side 
effects based on age group and severity category are shown in Figure 2. A 2 (Age Group: 
younger adults, older adults) x 2 (Warning Category: non-CYD, CYD) mixed ANOVA on 
ratings found an effect of age group, F(1, 46) = 4.85, MSE = 3.63, p = .03, ηG
2
 = .07, such that 
older adults (M = 6.76, SD = 1.38) gave higher ratings to the side effects than younger adults (M 
= 5.91, SD = 1.32).  There was a main effect of warning category, F(1, 46) = 13.12, MSE = 1.52, 
p = .001, ηG
2
 = .08, such that CYD side effects were rated more negatively (M = 6.79, SD = 1.21) 
than non-CYD side effects (M = 5.88, SD = 1.06). The interaction between age group and 
warning category was not significant, F(1, 46) = 2.20, p = .14.  
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 The proportions of side effects recalled based on age group and warning category is shown 
in the lower portion of Figure 2. Older adults remembered as many side effects as younger 
adults, while warning category only had a minor influence on recall. A 2 (Age Group: younger 
adults, older adults) x 2 (Warning Category: non-CYD, CYD) mixed ANOVA on recall found a 
non-significant effect of warning category, F(1, 46) = 2.51, MSE = .04, p = .12, ηG
2
 = .03, such 
that side effects that were categorized as CYD  appeared to be  recalled slightly more often than 
side effects not categorized as CYD, although the difference did not reach statistical significance. 
Both the main effect of age group and the interaction between age group and warning category 
were non-significant (ps > 0.15).  One reason for the lack of an effect of warning label may be 
that items were intentionally counterbalanced in these conditions, thus controlling for item type, 
and making the only distinction being if the item was presented in red or black color.  This 
would make the differentiation between CYD and non-CYD purely a feature binding task, and 
perhaps participants did not engage in processing that allowed for later retrieval of this 
information during recall.    
 Mean proportions of side effects identified as “CYD” on the source recognition test are 
shown in Figure 3. A 2 (Age Group: younger adults, older adults) x 2 (Measure: hits, false 
alarms) mixed ANOVA revealed a main effect of measure, F(1, 46) = 152.07, MSE = .04, p < 
.001, ηG
2
 = .64, such that participants overall had more hits (M = .60, SD = .26) than false alarms 
(M = .10, SD = .12). Critically, age group interacted with measure, F(1, 46) = 8.58, MSE = .04, p 
< .01, ηG
2
 = .09. Older adults (M = .52, SD = .22) had significantly fewer hits than younger 
adults (M = .68, SD = .27), t(46) = 2.35, p = .02, d = .65, whereas the opposite pattern was found 
for false alarms, t(46) = 2.22, p = .03, d = .63, such that older adults (M = .13, SD = .13) 
misidentified more side effects as CYD than younger adults (M = .06, SD = .09).  The above age 
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group by measure interaction supports the claim that older adults may be more reliant on 
familiarity and not recollection when recognizing important information (e.g., Jacoby, 1991). 
Additionally the interaction illustrates that, while older adults are sensitive to remembering 
information based on its value (in free recall), they may also have difficulty binding that 
importance to specific side effect items.  Consistent with the associative deficit hypothesis (see 
Naveh-Benjamin, 2000), the only feature that distinguished CYD and non-CYD items in the 
source recognition task were the color they were presented in at encoding, but the CYD items 
were not necessarily more severe.  Lastly, although more older adults reported paying attention 
to the listed side effects of medications they are currently taking (67%) compared with younger 
adults (33%), this factor did not influence performance on either dependent measure of ratings or 
recall, nor performance on the source recognition test.  
 The results of Experiment 2 bear some similarities and some differences with the findings 
from Experiment 1. Importantly, there was no effect of age group on recall of the side effects, 
suggesting that older adults can remember side effects as well as younger adults, perhaps due to 
schematic support. However, there were differences between objective (i.e., CYD warnings) and 
subjective value (i.e., participants’ negativity ratings), and the degree to which this influenced 
recall.  In the later source recognition test, hit and false alarm performance provides further 
evidence for gist-based memory in older adults (Koutstaal & Schacter, 1997) and also the use of 
familiarity contributing to false recognition in older adults (Jacoby, 1991; Rhodes et al., 2008). 
Younger adults were able to correctly identify more CYD side effects than older adults (i.e., 
hits), while older adults incorrectly identified more non-CYD side effects as CYD compared to 
younger adults (i.e., false alarms). This result is surprising given that older adults recalled as 
many CYD severe side effects as younger adults during the free recall test that occurred 
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immediately prior to the source recognition test. Taken together, these findings may represent 
both the benefits (enhance free recall) and costs (greater false alarm rates) of schematic support 
for older adults when recalling and recognizing important side effect information.   
General Discussion 
 The overall goal of the current studies was to explore the impact of different value types 
(i.e., objective and subjective) and the occurrence of value-directed remembering in the 
ecologically valid context of memory for medication side effects in younger and older adults. 
Across both experiments there was no effect of age on recall, a somewhat striking observation 
given that age-related effects on most other tests of free recall are usually quite pronounced.  
Importantly, in some cases, participants were sensitive to value in their memory for the side 
effects, but in other cases both young and older adults’ recall did not differentiate between side 
effect that that should be reported to a doctor (Contact Your Doctor, or CYD), and those that do 
not, when this information was demarked using a perceptual cue during encoding (red font).  In 
addition in Experiment 2, identification of the “Contact Your Doctor” items in the source 
recognition test showed that older adults had a greater frequency of false alarms and fewer hits 
relative to younger adults. 
 The lack of age-related differences in free recall of side effect information may be due to 
older adults’ utilization of schematic support, or their relatively greater experience with 
medication and associated side effects, which could have assisted in their ability to recall the side 
effect information (Castel, 2005; 2007; Castel et al., 2013; Miller, 2003; Morrow, Leirer, Altieri, 
& Fitzsimmons, 1994; Umanath & Marsh, 2014). While there were no significant differences 
between those who reported usually attending to side effects when taking medication in real life 
and those who did not, it may be that side effects are more important in general for older adults 
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to attend to, combined with greater experience with these effects, and this could lead to memory 
benefits via a survival (cf. Kang et al., 2012), or self-reference effect (cf. Gutchess, Kensinger, & 
Schacter, 2007).  Older adults may also consider potential severe side effects as more life-
threatening, and this could lead to an emotional component in terms of remembering this 
important information.  In Experiment 2, older adults rated the side effects as more severe or 
negative overall compared to younger adults. Based on these relatively higher ratings, it stands to 
reason that older adults could have found the to-be-learned material to be more valuable, 
emotional, or important than younger adults did, which could have contributed to the negligible 
effects of age.  
 Older adults may have benefitted from contextual support in the present task (see also Hess, 
2005), as well as the use of schematic support based on prior experience (e.g., Craik & Bosman, 
1992; Castel, 2005).  The results from the present study indicate that memory for medication side 
effects appears to be one domain in which older adults do not show large age-related declines, at 
least when tested immediately and when focusing on a single hypothetical medication. However, 
older adults do show a cost in terms of inaccurately recognizing certain side effects (as 
evidenced by greater false alarms relative to younger adults).  Since the prevalence of medication 
usage increases in later adulthood, the need for additional awareness of medication-related issues 
such as memory for potential side effects is critical (Hines & Murphy, 2011; Moore, Whiteman, 
& Ward, 2007; Qato et al., 2008). Practically, this work may help doctors and medical providers 
better inform their patients about their prescribed medications, and help to organize treatment 
plans based on what symptoms or side effects the patient views are more severe or adverse (as 
side effects people perceive as more negative appear to be better remembered). 
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 The results from the recognition source memory test in Experiment 2 provide support for the 
idea that older adults may rely more heavily on familiarity compared with younger adults when 
retrieving information (Jacoby 1991; Jacoby et al., 2005; 2010), in that they incorrectly identified 
significantly more side effects as the critical CYD effects compared to younger adults, 
illustrating one potential cost of schematic support.  While prior research has shown that age-
related differences in recognition are smaller than in recall (e.g., Craik & McDowd, 1987), older 
adults may be strategically recalling important side effects in the present task, and then relying 
on familiarity of the side effects on the later recognition test.  Specifically, older adults may have 
greater difficulty updating the value or importance of to-be-remembered information (Friedman 
& Castel, 2013), and creating new associations with that information (Naveh-Benjamin, 2000), 
especially if competing yet irrelevant information has to be suppressed (inhibitory deficits; 
Hasher & Zacks, 1988; Lustig, Hasher, & Zacks, 2007).  
 It is possible that the source recognition test used in Experiment 2 may have been too 
difficult, in that older adults had to specifically remember which of these typically mild side 
effects were categorized as especially important and severe. Additionally, if all of the side effects 
were presented simultaneously during the test, then older adults may be able to use relative 
familiarity to identify the critical side effects, despite the side effects not usually being life-
threatening.  The “incongruency” between those two types of value cues (i.e., the side effect is 
usually not serious, but in this instance it is) may illustrate a potential cost of schematic support, 
as it creates interference when updating critical information that is typically considered less 
important.  This finding is crucial when one considers the potential dangers associated with 
taking medications.  It would also be important to assess confidence both during encoding and at 
test, when participants recall and recognize potentially life-threatening side effects.  Older adults, 
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in particular, may have difficulty recognizing that they are experiencing a potentially life-
threating side effect that is typically considered or thought to be subjectively mild, or could 
misidentify the symptoms of a less serious side effect as something requiring immediate medical 
attention.   
   In the present study, both younger and older adults were able to effectively remember 
important side effect information.  We note that the current work examined relatively short-term 
memory for side effects; future research could examine these issues using longer delays (days or 
weeks), or use side effects that could vary in terms of frequency or duration.   Also, it maybe that 
if given more time to recall all items (without attention to value), then older adults would recall 
some of the lower value items, or perhaps be able to recognize them on a later recognition test. 
Further examination of the specific role of emotion or anxiety associated with remembering side 
effects would be informative, to determine how emotional value might be related to later recall. 
Future research could also include a stronger cue or event-based prospective memory component 
(use of multiple drugs and various combinations of side effects) to better reflect real-world 
medication use.  The investigation of prospective memory may be especially critical as it is often 
necessary for one to later report experienced (and either subjectively or objectively important) 
side effects to their physician (see Einstein & McDaniel, 1990; Henry, MacLeod, Phillips, & 
Crawford, 2004; Liu & Park, 2004; McDaniel & Einstein, 2007; Scullin, Bugg, & McDaniel, 
2012; Webb et al., 2008; Zogg et al., 2012).  This area of research has the potential to benefit 
both younger and older adults, and to provide practical and theoretical insight regarding how 
people can selectively remember important medication-related information.  
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Figure 1.  The mean ratings (top panel) and proportion recalled (bottom panel) of side 
effects in Experiment 1 based on the severity categories and age group of the participants. 
Error bars represent standard error of the mean. 
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Figure 2.  The mean ratings (top panel) and proportion recalled (bottom panel) of side 
effects in Experiment 2 based on the assigned warning categories and the age group of the 
participants. CYD refers to “Contact Your Doctor” if the participant were to experience 
these side effects.  Since there were three times as many non-CYD side effects as there 
were CYD side effects, separate bars are shown to depict overall performance (“All”, 
shown on the left side of each graph) as well as the non-CYD and CYD side effects. Error 
bars represent standard error. 
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Figure 3.  The mean proportion of items identified as “CYD” (contact your doctor if 
you experience these side effects) in the source recognition task that followed the 
recall test in Experiment 2. Error bars represent standard error. 
 
